- Report
- May 2024
- 129 Pages
Global
From €5944EUR$6,499USD£5,060GBP
- Report
- May 2024
- 128 Pages
Global
From €5944EUR$6,499USD£5,060GBP
- Report
- May 2024
- 140 Pages
Global
From €5944EUR$6,499USD£5,060GBP
- Report
- May 2024
- 134 Pages
Global
From €5944EUR$6,499USD£5,060GBP
- Report
- August 2022
- 120 Pages
Global
From €4116EUR$4,500USD£3,503GBP
- Report
- July 2022
- 131 Pages
Global
From €4116EUR$4,500USD£3,503GBP
- Report
- October 2022
- 138 Pages
Global
From €4070EUR$4,450USD£3,464GBP
- Report
- April 2025
- 70 Pages
Japan
From €4344EUR$4,750USD£3,698GBP
- Report
- February 2024
- 70 Pages
United States
From €4344EUR$4,750USD£3,698GBP
- Report
- February 2024
- 70 Pages
China
From €4344EUR$4,750USD£3,698GBP
- Report
- February 2024
- 70 Pages
Thailand
From €4344EUR$4,750USD£3,698GBP
- Report
- February 2024
- 70 Pages
Philippines
From €4344EUR$4,750USD£3,698GBP
- Report
- February 2024
- 70 Pages
Oman
From €4344EUR$4,750USD£3,698GBP
- Report
- February 2024
- 70 Pages
Iran
From €4344EUR$4,750USD£3,698GBP
- Report
- April 2024
- 30 Pages
Global
From €2972EUR$3,250USD£2,530GBP
- Report
- April 2024
- 30 Pages
Global
From €2972EUR$3,250USD£2,530GBP
- Report
- April 2024
- 30 Pages
Global
From €2972EUR$3,250USD£2,530GBP
- Report
- February 2024
- 30 Pages
Global
From €2972EUR$3,250USD£2,530GBP
- Report
- January 2024
- 120 Pages
Global
From €7271EUR$7,950USD£6,189GBP
- Report
- January 2024
- 120 Pages
Global
From €7271EUR$7,950USD£6,189GBP

The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin.
Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more